WA
HZNP

WFG Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

WFG Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$0 Sell
1
-250
-100% -$3.11K ﹤0.01% 1716
2017
Q1 		$4K Sell
251
-1,800
-88% -$29.2K ﹤0.01% 1264
2016
Q4 		$33K Sell
2,051
-19,050
-90% -$345K 0.01% 821
2016
Q3 		$383K Buy
21,101
+15,550
+280% +$304K 0.1% 218
2016
Q2 		$91K Buy
5,551
+1,400
+34% +$22.6K 0.02% 527
2016
Q1 		$69K Buy
4,151
+2,101
+102% +$36.8K 0.02% 579
2015
Q4 		$44K Buy
2,050
+850
+71% +$16.5K 0.01% 702
2015
Q3 		$24K Buy
+1,200
New +$37.9K 0.01% 847
2014
Q3 		– Sell
-1,000
Closed -$16K – 2195
2014
Q2 		$16K Buy
+1,000
New +$14.3K ﹤0.01% 1359

Other funds holding HZNP

SCM
Scopia Capital Management New York $144M AUM 25.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return